C14ORF138 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.080600E-01
Normal-vs-Stage2
4.941600E-01
Normal-vs-Stage3
3.593800E-01
Normal-vs-Stage4
4.048400E-01
Stage1-vs-Stage2
9.528800E-01
Stage1-vs-Stage3
2.431400E-01
Stage1-vs-Stage4
9.746800E-01
Stage2-vs-Stage3
1.967830E-01
Stage2-vs-Stage4
9.323400E-01
Stage3-vs-Stage4
2.651600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.029800E-01
Normal-vs-AfricanAmerican
4.734600E-01
Normal-vs-Asian
3.619000E-01
Caucasian-vs-AfricanAmerican
7.110800E-01
Caucasian-vs-Asian
3.722300E-02
AfricanAmerican-vs-Asian
2.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.896200E-01
Normal-vs-Female
4.950400E-01
Male-vs-Female
8.944400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.021800E-01
Normal-vs-Age(41-60Yrs)
5.431600E-01
Normal-vs-Age(61-80Yrs)
4.670800E-01
Normal-vs-Age(81-100Yrs)
4.642400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.959800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.915600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.666100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.656300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.613800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.408200E-01
Normal-vs-Daily Drinker
4.952200E-01
Normal-vs-Weekly Drinker
4.161200E-01
Normal-vs-Occasional Drinker
6.052400E-01
Normal-vs-Social Drinker
4.517800E-01
Non Drinker-vs-Daily Drinker
4.192800E-01
Non Drinker-vs-Weekly Drinker
7.132200E-01
Non Drinker-vs-Occasional Drinker
4.778400E-02
Non Drinker-vs-Social Drinker
8.920200E-01
Daily Drinker-vs-Weekly Drinker
2.998400E-01
Daily Drinker-vs-Occasional Drinker
2.000800E-01
Daily Drinker-vs-Social Drinker
5.525200E-01
Weekly Drinker-vs-Occasional Drinker
4.940000E-02
Weekly Drinker-vs-Social Drinker
6.504400E-01
Occasional Drinker-vs-Social Drinker
9.230400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.489900E-02
Normal-vs-Grade 2
1.655880E-02
Normal-vs-Grade 3
4.602400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.891800E-01
Grade 1-vs-Grade 3
8.338400E-01
Grade 1-vs-Grade 4
9.489900E-02
Grade 2-vs-Grade 3
5.998600E-01
Grade 2-vs-Grade 4
1.655880E-02
Grade 3-vs-Grade 4
4.602400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.561800E-01
Normal-vs-NonDiabetic
4.871000E-01
Diabetic-vs-NonDiabetic
4.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.973600E-01
Normal-vs-NoPancreatitis
4.834400E-01
Pancreatitis-vs-NoPancreatitis
1.956380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.678600E-01
Normal-vs-N1
4.999000E-01
N0-vs-N1
4.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.357200E-01
Normal-vs-TP53-NonMutant
5.529200E-01
TP53-Mutant-vs-TP53-NonMutant
1.960590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
